Company Overview 

Elanco is a global, innovation-driven company that develops and markets products to improve animal health and protein production in more than 75 countries. Elanco employs more than 2,300 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation.

Elanco is committed to protein production, companion animal health and food safety. Elanco products help the food industry produce an abundant supply of safe, nutritious and affordable food. Additionally, they enhance animal health, wellness and the human-pet bond. Elanco Companion Animal Health is leading the way in pet medicine, helping pets live longer, healthier, happier lives. Elanco Food Solutions markets food-safety products and services to the food animal industry. Elanco's global headquarters is in Greenfield, Indiana, USA, and is also the home of the United States business operations.

History

For more than half a century, Elanco has helped shape the animal health industry around the world. We introduced our first antibiotic for veterinary use only in 1953. Since then, Elanco has brought more than 35 agricultural and animal health products to the global marketplace, including food industry products such as antibacterials, parasiticides, anticoccidials, productivity enhancers and feed additives, as well as pet medicines and food safety solutions.

Whether for livestock or pets, Elanco is committed to research, development and implementation of products that benefit animals, consumers and the environment. We partner with the most innovative companies worldwide to develop products that increase food production, enhance food safety, and help companion animals live longer, happier, healthier lives.